https://www.selleckchem.com/pr....oducts/cilengitide-e
The nonfinancial cost was $25.4 billion. The economic costs associated with sleep disorders are substantial. The financial component of $10.0 billion is equivalent to 0.73% of Australian gross domestic product. The nonfinancial cost of $25.4 billion represents 3.2% of total Australian burden of disease for the year. Health system costs of these disorders are low relative to those associated with their consequences, suggesting greater expenditure on detection, treatment and prevention is warranted. The economic
Like
Comment
Share
